Physiopathology of splanchnic vasodilation in portal hypertension
Open Access
- 1 January 2010
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 2 (6), 208-20
- https://doi.org/10.4254/wjh.v2.i6.208
Abstract
In liver cirrhosis, the circulatory hemodynamic alterations of portal hypertension significantly contribute to many of the clinical manifestations of the disease. In the physiopathology of this vascular alteration, mesenteric splanchnic vasodilation plays an essential role by initiating the hemodynamic process. Numerous studies performed in cirrhotic patients and animal models have shown that this splanchnic vasodilation is the result of an important increase in local and systemic vasodilators and the presence of a splanchnic vascular hyporesponsiveness to vasoconstrictors. Among the molecules and factors known to be potentially involved in this arterial vasodilation, nitric oxide seems to have a crucial role in the physiopathology of this vascular alteration. However, none of the wide variety of mediators can be described as solely responsible, since this phenomenon is multifactorial in origin. Moreover, angiogenesis and vascular remodeling processes also seem to play a role. Finally, the sympathetic nervous system is thought to be involved in the pathogenesis of the hyperdynamic circulation associated with portal hypertension, although the nature and extent of its role is not completely understood. In this review, we discuss the different mechanisms known to contribute to this complex phenomenon.Keywords
This publication has 141 references indexed in Scilit:
- Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic ratsJournal of Hepatology, 2008
- Mechanisms of extrahepatic vasodilation in portal hypertensionGut, 2008
- NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive ratsGut, 2007
- Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptorsBritish Journal of Pharmacology, 2006
- Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive ratsJournal of Hepatology, 2005
- Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to α-adrenergic vasoconstriction in rats with cirrhosisJournal of Hepatology, 2001
- The Akt kinase signals directly to endothelial nitric oxide synthaseCurrent Biology, 1999
- Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic ratsLife Sciences, 1995
- Altered Cerebral Blood Flow and Glucose Metabolism in Patients with Liver Disease and Minimal EncephalopathyJournal of Cerebral Blood Flow & Metabolism, 1991
- Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosisJournal of Hepatology, 1991